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Genes linked to the H-2 major histocompatibility complex and controlling the 
immune response to a variety of macromolecular antigens have been described 
in mice (1). However, the genetic control of the immune response to only a few 
natural  globular proteins has been studied  (1-3) largely because of their anti- 
genic complexity. Among these, staphylococcal nuclease (nuclease) is a conven- 
ient model, since it is a relatively simple protein, of mol wt only 16,800,  consist- 
ing  of a  single  polypeptide  chain  with  no  disulfide  bridges.  Its  amino  acid 
sequence  and  three-dimensional  structure  at  high  resolution  have  been  de- 
termined  (4, 5). 
In a previous study, Lozner et al. (3) demonstrated that the antibody response 
of mice measured 3 wk after a  single immunization  with nuclease in complete 
Freund's adjuvant was under H-2-1inked Ir gene control. The H-2 linkage was 
demonstrated both by a  comparison of congenic resistant  strains,  which differ 
only  at H-2,  and  by a  formal  genetic  linkage  analysis  in  an  F2  generation. 
Furthermore,  the Ir  gene  (referred  to  as  "/r-Nase")  was  mapped  in  the I-B 
subregion of H-2 using recombinant mice. 
We now present an analysis of the time-course of response to multiple immu- 
nizations with nuclease in four strains of mice. In addition we have analyzed the 
antibody response to several large polypeptide fragments from nuclease in five 
strains.  Our results demonstrate that the magnitude of response to nuclease is 
controlled by additional non-H-2-1inked genetic factors. Further,  we have iden- 
tified a  second H-2-1inked Ir gene  (or genes)  involved in the response to this 
globular protein.  Lastly, we present evidence that the antibody response to one 
fragment  of nuclease,  comprising residues 99 to  149,  appears to be under  the 
same genetic control as the response to the native protein. 
Materials  and Methods 
Mice.  All mice were obtained from The Jackson Laboratory, Bar Harbor, Maine, and were 6- 
8-wk old at the start of each experiment. Only female mice were used except for the DBA/1 mice 
immunized with fragments (1-126) and (6-48), which were male. The strains used, with their H-2 
haplotypes and responder status from the earlier studies of initial response to whole nuclease, 
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were A/J (H-2 a, high), C57BL/10 Sn (H-2 ~, low), B10.A/SgSn (H-2%  high), SJL/J (H-2", high), 
and DBA/1J (Ho2  q, low). 
Immunization Schedule.  8-12 mice of each strain were used for each immunogen. Mice were 
bled from the tail, and the sera were stored frozen to be assayed individually. Preimmune serum 
was  obtained  from each  mouse  to  be used  as  a  control for that single  mouse.  Animals  were 
immunized intraperitoneally with 6 nmol of antigen, native protein or fragment (equivalent to 
100  ~g of whole  nuclease),  emulsified  1:1  in complete  Freund's  adjuvant  (Difco  Laboratories, 
Detroit, Mich., H37Ra). The first bleed was taken 21 days later, and the animals were then boosted 
with one-tenth as much antigen i.p.  in 0.1  ml of phosphate-buffered saline (PBS). 1 The second 
bleed was obtained 10 days later,  and successive boosts and bleeds were carried out at  10-day 
intervals. 
Purification of Staphylococcal Nuclease.  Nuclease was purified from the supernatant culture 
medium  of Staphylococcus aureus,  Foggi  strain,  by the  method of Bohnert and Taniuchi  (6). 
Additional purification steps were taken as described in the accompanying paper (7), to ensure the 
purity of the preparation. 
Preparation of Fragments of Nuclease.  Fragment (99-149).  Fragment (99-149) was prepared 
by cyanogen bromide cleavage according to the method of Taniuchi and Anfinsen (8). The result- 
ing product was judged over 90% pure by two-dimensional tryptic peptide  mapping (9)  and its 
ability to complement with fragment (1-126) to produce enzymic activity (4). 
Fragment (1-126).  Fragment (1-126) was prepared by the method of Taniuchi and Anfinsen 
(10). Fragment (127-149) was obtained as a byproduct, which was further purified by gel filtration 
on Sephadex G-50SF. The preparation of fragment (1-126) had less than 0.5% contamination with 
native nuclease after two passes through deoxythymidine diphosphate-Sepharose (pdTp-Sepha- 
rose) affinity columns as indicated by its sp act of 12 U/mg. It showed a single line on Ouchterlony 
double immunodiffusion plates against both goat antinuclease and goat anti-fragment (1-126). 
Fragment (6-48).  Fragment (6-48) was prepared by the method ofTaniuchi et al. (11) and was 
a gift of Dr. John Gerlt. It was further purified by affinity chromatography on pdTp-Sepharose to 
remove any whole nuclease or fragment (49-149). The resulting purified fragment (6-48) had no 
detectable nuclease activity in a  solution of 3.2 mg/ml of peptide. 
Radiolabeling of Peptide Fragments.  Fragments (99-149) and (1-126) were carbamoylated with 
[14C]KCNO  (Amersham/Searle  Corp.,  Arlington  Heights,  Ill.,  specific radioactivity,  55  mCi/ 
mmol) by the method of Stark (12) which leads to the selective carbamoylation of the amino-termi- 
nal a-amino groups 100-fold faster than the E-amino groups of lysine residues. The procedure was 
modified as follows: for 0.81/~mol of fragment (99-149), a 70-fold excess of [~4C]KCNO  was used at a 
final concentration of 0.2 M in 0.1 M triethanolamine hydrochloride pH 7.0, with a reaction time of 
70 min at 25°C,  followed by gel  filtration on a  1  ×  95-cm column of Sephadex G-10 in 0.1  M 
NH4OAc, pH 7.4, to remove free cyanate. The resulting preparation had a specific radioactivity of 
50/~Ci/gmol corresponding to about 0.91 mol of cyanate incorporated per mol of peptide. 
Fragment (1-126) was carbamoylated in a  similar fashion except that a  50-fold molar excess of 
[~4C]KCNO was used and the reaction time was 90 min at 23°C. The final preparation had a specific 
radioactivity of 141/~Ci//xmol corresponding to an average incorporation of 2.5 mol of cyanate per 
mol of peptide. 92% of the radioactivity was precipitable by 5% trichloroacetic acid in the presence 
or absence of excess unlabeled cyanate, and 91% could be precipitated by excess goat antinuclease 
with polyethylene glycol (see below). 
Radioimmunoassay of Antibody Binding to Nuclease Peptide Fragments.  Antibodies binding 
to 14C-carbamoylated peptide fragments of nuclease were assayed by a  modified Farr-type tech- 
nique using polyethylene glycol to precipitate immunoglobulin and bound antigen based on the 
method of Desbuquois and Aurbach (13).  10 gl of the serum to be assayed was placed into the 
bottom of a  400 gl polyethylene conical microfuge tube (Beckman Instruments, Inc., Fullerton, 
Calif.), followed by 30/xl of PBS, pH 8.0, and 10 gl of an 80 gM solution of 14C fragment (99-149) (25 
gCi//xmol, about 44,000 cpm total) or 10 gl of a  70 ttM solution of 14C fragment (1-126) (29 gCi/ 
/~mol, about 40,000 cpm total) in PBS. After brief mixing on a  Vortex-Genie mixer, the reaction 
mixture was incubated in capped tubes for 15-20 min at room temperature followed by 1-2 h at 4°C. 
Then 50/xl of prechilled 20% (wt:wt) polyethylene glycol in PBS, pH 8, (or 25% wt:wt in the case of 
Abbreviations  used in this paper:  PBS,  phosphate-buffered saline  (0.15 M  NaC1,  0.015  M 
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fragment 99-149) was added.  After vigorous mixing the tubes were  centrifuged in a  Beckman 
microfuge Model 152 at 10,000 g for 2 min at room temperature and then rechilled in ice. The clear 
supernatant solutions were transferred to 10 ml of Instabray (Yorktown Research Inc., Hacken- 
sack,  N. J.) in a  scintillation vial along with two rinses of 50 ~tl each of prechilled 10%  (wt:wt) 
polyethylene glycol. These were counted on a  Searle Mark III liquid scintillation counter for 10 
min or 40,000 total counts to assess the fraction of free label. The pellets were dissolved in 100 ~tl of 
1 N acetic acid (demonstrated not to quench) (or H20 for fragment 99-149) and rinsed with 200 ~l of 
H20 followed by Instabray and counted as above to assess bound radioactivity. For assay of sera 
raised to fragment (6-48), 3 ~tl of 70 ~M '4C fragment (1-126) was used,  and the vol of PBS was 
increased to 37 ~l (see below). 
The following controls were necessary in the development and interpretation of the assay: The 
optimum concentration and pH for polyethylene glycol giving quantitative precipitation of anti- 
bodies and bound antigen with the lowest blanks was 10-12% (wt:wt) at pH 8.0. The attainment of 
equilibrium was assured since no increase in binding occurred with incubation times from 1 min to 
22 h,  indicating rapid association kinetics.  The antibodies were found to remain active in the 
polyethylene glycol until centrifuged to separate phases. 
Blanks with control normal sera were usually close to 10% of the total radioactivity added, with 
no evidence for saturation even up to 10-20 ~M free peptide. This observation suggests that the 
binding by normal sera is of low affinity (KA ~10  ~ M -1) and therefore probably "nonspecific." The 
antigen bound by the preimmune serum of each mouse was subtracted from that bound by each 
immune serum from the same mouse. 
A  preliminary binding curve  on pooled serum  was  used  to  determine  the concentration of 
antigen necessary to saturate the highest titered antiserum, and this constant concentration was 
used for all antisera to that particular antigen. Antisera to fragments (1-126) and (6-48) were 
assayed in duplicate. 
Assay of Antinuclease Antibodies  by Inhibition of Enzymatic Activity.  The assay for antinu- 
clease based on inhibition of enzymatic activity was modified from that described by Lozner et al. 
(3).  10  ~l  of a  nuclease  standard  (5  ~g/ml  with  sp  act  2,000  U/ml) and  10  ~1  of a  dilution of 
antiserum or saline control were incubated at room temperature for 5 min. An aliquot of 10 ~1 of 
this mixture was then transferred to  1  ml  of nuclease assay  mixture  (3),  and the  change  in 
absorbance at 260 nm for the experimental sample was subtracted from that for the control. The 
difference, after multiplication by the dilution factor, was defined as the units of nuclease activity 
inhibited per ml of serum, in which 1 U  =  I absorbance U/min, which corresponds to 32.8 pmol of 
nuclease at this specific activity. Although the assay depends on inhibition of enzymatic activity, 
at least in the case of goat antinuclease,  no noninactivating antinuclease antibodies could be 
detected (D. H. Sachs, A. N. Schechter, A. Eastlake,  and C.  B. Anfinsen, unpublished observa- 
tion). 
It was noted that the apparent inhibition units per milliliter serum increased with increasing 
dilution of antiserum, but that usually a plateau was reached at high dilution. This nonlinearity 
was not observed when a  goat antinuclease serum fractionated by affinity chromatography to be 
monospecific for the region 99-126 of nuclease was used (14).  The most probable explanation for 
this nonlinearity thus  seems  to  be  that with  multispecific  antisera  in  which  more  than  one 
antibody can bind simultaneously to a  nuclease molecule, multiple hits are scored as single hits. 
This  phenomenon is  analogous  to  that which  causes  unusually  steep  displacement curves  in 
radioimmunoassays (15). Therefore the amount ofnuclease inhibited at high dilution of antiserum 
(large antigen excess), at which multiple hits are rare and the antibodies are saturated, is the best 
estimate of total antibody concentration. For this reason, multiple dilutions of antiserum were 
assayed,  and  the  plateau  value  (when  a  plateau  could  be  reached)  or  the  highest  value  of 
inhibition units per milliliter serum was used. 
Statistical Analysis.  Mean of the differences between paired immune and preimmune sera 
was tested for significance by a two-sided Student's t test according to the method of Snedecor and 
Cochran for paired data (16).  A two-way analysis of variance was performed (16) to compare the 
relative magnitudes  of the  experimental  variance  (judged by variation of replicates)  and the 
variance due to actual variability among the 6-12 animals within a  group. 
A multivariate analysis of variance (17) using the program LDU 042 from the DCRT Program 
Library  of the  National  Institutes of Health  was  performed  to  compare  the significance of the 
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three immune bleeds) and correspondingly to compare the three antigens across the panel of five 
strains. 
Results 
Progression of the Antibody Response to Nuclease with Boosting.  The con- 
centration  of antinuclease  in the serum of mice of the two highest responder 
strains,  A/J  and  SJL,  rose  sharply  with  successive boosts of nuclease  and 
reached a plateau after the third immunization (Fig. 1, left). The plateau level of 
response,  about  1,000-1,400  inhibition  U/ml  of serum,  corresponds  approxi- 
mately to 33-46 ~M antibody binding site concentration. 
In contrast, the antibody response of the B10.A mice (Fig. 1, right) increased 
only about threefold to a  plateau level after four immunizations  of about 120 
inhibition  U/ml of serum,  only one-tenth  the  maximum  response of the  A/J 
mice.  Since  the  A/J  and  B10.A  strains  share  the  same H-2  haplotype,  this 
marked difference throughout the course of the response must be attributed to 
one or more non-H-2-1inked genes. Thus, within the group of strains classed as 
high responder in H-2 type, there are additional non-H-2-1inked factors which 
influence the magnitude of the antibody response to nuclease. 
When the progression of antibody response with boosting was compared in the 
two strains bearing the same B10 genetic ~background" (non-H-2) genes (Fig. 1, 
right),  the  B10.A  (H-2 ~,  high  responder)  response  was  initially  four times 
higher  than  that  of the  C57BL/10  (H-2 b,  low responder)  in  agreement  with 
previous observations (3). However, after three immunizations a difference was 
no  longer  observed.  With further  immunization,  the  C57BL/10 made just as 
much antinuclease as the B10.A. This phenomenon was reproducible in a second 
group of five C57BL/10 and nine B10.A mice that were given three immuniza- 
tions (data not shown). 
Antibody Responses  to Nuclease Fragments.  An artist's  representation  of 
the three-dimensional structure of nuclease is shown in Fig. 2. The region from 
residues 99-149 contains two of the three  a-helices in the native protein.  The 
region from residues 1-126 overlaps the former region from residues 99-126. A 
subregion  of fragment  (1-126),  from residues 6-48,  representing  roughly  the 
amino-terminal  third of the whole protein, was also studied. Each of the three 
fragments was used as immunogen to prime and boost mice of the five strains 
studied. 
The mouse antibodies to fragments (99-149) and (1-126) discussed below have 
been shown to be specific for the random conformation  2 in that they react with 
native nuclease about two orders of magnitude less well than with the random 
conformation fragments (data not shown). 
Antibody Response to Nuclease Fragment (99-149).  The mean concentra- 
tion of antibody binding sites to fragment (99-149), measured as the difference in 
saturation  binding  between immune  and  preimmune  serum  from  the  same 
mouse, is shown in Fig. 3 for each of five strains.  As in the response to whole 
nuclease, the antibody response to fragment (99-149) was found to be high in A/J 
and SJL,  intermediate  in B10.A,  and low in C57BL/10 and  DBA/1.  However, 
2 "Random" conformation is used to  mean the  array  of many non-native conformations in 
equilibrium with one another in solution. 1400 
1200 
looo 
z 
800 
E 
i  600 
z 
BERZOFSKY~  SCHECHTER,  SHEARER,  AND  SACHS 
400 
200 
0 
@ 
1  ° 
T 
2 o  3 ° 
BLEED 
SJL 
~] A/J 
140 
0  C57BL/10 
12o  []  mo.A 
~-  80 
g 
~-  60 
4O 
4 °  5  °  Prebleed  1  °  2  °  3 ° 
BLEED 
4  o  5 ° 
FIG.  1.  Antibody response of four strains of mice to staphylococcal nuclease. (a) open bars, 
SJL/J;  hatched  bars,  A/J.  (b)  open  bars,  C57BL]10; hatched  bars,  B10.A.  Assay and 
inhibition units  are as described in  Materials and Methods.  Numbers on the abscissa 
represent the number of immunizations before the bleed from which the sera are assayed. 
All data are from sera pooled from 8 to 12 animals. Error bars represent ranges of two to four 
replicates, not standard errors. 
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FIG. 2.  An artist's representation of the three-dimensional structure of staphylococcal 
nuclease (8).  Numbers indicate approximate positions of those residues demarcating the 
fragments under study:  (6-48),  (1-126),  and (99-149). 
whereas  the antibody response to whole nuclease was low but significant in the 
initial sera of the C57BL/10  mice and increased with boosting, the response to 
fragment  (99-149)  was not statistically different from zero  in this strain  even 
after three  immunizations.  Thus,  within  the limits of resolution of the present 
assay system,  responses to the fragment  (99-149)  were all-or-none rather  than 
high or low. 116 
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Fro.  3.  Antibody response of five  strains of mice to nuclease fragment (99-149). The 
strains of mice are indicated at the bottom. The numbers directly above the strain designa- 
tions indicate the number of immunizations before the bleed shown.  Response was mea- 
sured as concentration of specific binding  sites determined from the difference in binding  at 
large antigen excess between the given immune bleed and the preimmune bleed from the 
same mouse, by radioimmunoassay (see Materials and Methods).  The bars represent the 
means of these differences  from preimmune bleeds for 5-12 individual mice in each group, 
and the error bars are standard errors of the mean. The + and -  symbols above the bleed 
numbers indicate the level of statistical significance of the mean of the differences relative 
to zero, determined by a two-sided Student's t test, according to the key in the figure. 
The mean binding by the DBA/1  sera after three immunizations was lower 
than  the  mean  of  the  preimmune  sera  from  the  same  mice,  although  the 
difference was of borderline statistical significance (P <  0.05). We are currently 
pursuing possible implications of this observation. 
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Fro.  4.  Antibody  response  of five  strains  of mice  to  nuclease  fragment  (1-126).  The 
experimental details and format of the figure are as in Fig. 3. 
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antibodies made to fragment  (1-126)  by mice  immunized  and  boosted in the 
same fashion as with fragment  (99-149) are shown in Fig.  4.  A  multivariate 
analysis of variance  demonstrated  that  the  difference  in pattern  of response 
between fragment (99-149) and fragment (1-126) across the panel of five strains 
was highly significant  (P <4  ×  10-~). The major comparisons to be made with 
the response to fragment (99-149) and to whole nuctease are as follows: (a) The 
C57BL/10 mice showed a  statistically significant response to this fragment in 
the first two bleeds, in contrast to their failure to respond to fragment (99-149). 
The initial response was, in fact, higher than that of the A/J mice and compara- 
ble to that  of the  B10.A mice.  The  apparent  decrease in antibody level with 
boosting was not statistically significant by Student's t test and was not repro- 
ducible when the same sera were reassayed using 0.3 times as much antigen to 118  GENETICS  OF  IMMUNE  RESPONSE  TO  NUCLEASE  AND  ITS  PEPTIDES 
decrease background controls.  (b) The response of the B10.A mice to fragment 
(1-126) was much closer to that of the A/J mice, in contrast to the responses to 
fragment  (99-149)  and to whole nuclease  itself.  (c) The  SJL was a  very high 
responder  to  fragment  (1-126).  Whereas  both  the  initial  and  hyperimmune 
responses  of SJL  mice  were  comparable  to  those  of the  A/J mice  for whole 
nuclease (Fig. 1) and for fragment (99-149), they were more than fivefold higher 
than  those  of the  A/J mice for fragment  (1-126).  (d)  The  DBA/1 mice were 
nonresponders to both fragments as well as to whole nuclease. 
Antibody Response to Nuclease Fragment (6-48).  The antibody response to 
fragment (6-48) of nuclease was <0.3 t~M in binding sites in all strains tested. 
While this fragment serves as a control (in comparison with fragment [99-149]), 
indicating that size and charge are not the sole determinants of responsiveness 
patterns,  it is not very useful for comparing the pattern of response among the 
five strains because of this low immunogenicity.  It is nevertheless interesting 
that the initial response of the C57BL/10 mice was significant and nearly as high 
in  magnitude  as  the  A/J  response,  although  the  later  bleeds did  not  show 
statistically significant binding. In this sense, the pattern was more like that for 
fragment  (1-126)  (of which 6-48 is a part) than for fragment (99-149). 
Statistical Analysis of Components of Variance.  An analysis of the relative 
contributions to the standard  errors  (Figs.  3 and 4) of experimental  error,  as 
judged by variation among replicates, and of animal variability indicated that in 
most cases the experimental error was less than or comparable to the variance 
due to true biological variability among the animals within a  group. 
Discussion 
The striking difference between the AJJ and B10.A strains  which share the 
same "high responded'H-2 a haplotype indicates additional genetic factors in the 
control of the antibody response to nuclease that are not H-2 linked. Polygenic 
control of the response to a  complex antigen is not surprising.  This non-H-2- 
linked genetic control may be similar to that observed by Dorf et al. (18) for the 
random terpolymer poly-(L-Glu, L-Ala, L-Tyr) in the same pair of genetic back- 
grounds,  C57BL and A. 
The ability of the ~'low responder" C57BL/10 after multiple immunizations to 
raise an overall response to nuclease which is equal to that of the congenic high 
responder B10.A is further indication of the complexity of the genetic control. 3 
Therefore,  we have pursued the response  to fragments of the antigen  in the 
current  study and  have  examined  the  specificities of antibodies produced to 
native nuclease in the accompanying paper (7). 
The patterns of antibody response to whole nuclease and three of its fragments 
for the five strains of mice tested are summarized in simplified form in Table I. 
Although this table oversimplifies some of the details apparent in Figs. 3 and 4, 
it facilitates the discernment of certain general patterns. 
First, from a comparison of the vertical columns in the table, it appears that 
the response to fragment (99-149) best fits the original genetic distribution of  the 
3 It is noteworthy that this masking of the H-2-1inked effect with boosting is the opposite to that 
for the H-2-1inked Ir gene controlling responsiveness to poly(Tyr,Glu)-poly(D,L-Ala)--poly Lys, in 
which the H-2-1inked control is best detected after boosting (19). BERZOFSKY,  SCHECHTER~  SHEARER,  AND  SACHS 
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Summary of Response Patterns to Whole Nuclease and Nuclease Fragments 
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Antigen 
Strain 
Whole nuclease  Fragment 99-149  Fragment 1-126  Fragment 6-48 
A/J  High  High  High  Low 
C57BL/10  Low  Non  Low to intermed  Low 
B10.A  Intermed  Intermed  Intermed  Non 
SJL  High  High  Very high  Low 
DBA/1  Non  Non  Non  Non 
Responder status is given as non for those with mean response not statistically different from zero, 
or as qualitative relative level of  response (low, intermed, high, or very high responders) for those 
with mean response statistically significantly greater than zero (all relative to prebleeds from 
same mice). 
whole  antinuclease  response  in  terms  of the  relative  magnitudes  of the  re- 
sponses  among  the  five  strains.  In  fact,  whereas  the  C57BL/10  was  a  low 
responder to whole nuclease it appears to be a  nonresponder to fragment  (99- 
149). This observation suggests that the low response seen to whole nuclease in 
this strain may be due to a response to determinants between residues 1 and 99, 
and that this is manifested in a response to fragment (1-126) almost as high as 
that of the B10.A. This interpretation is in agreement with the results of a study 
of the  T-cell  proliferative  response  to  nuclease  and  its  fragments  (R.  H. 
Schwartz,  J.  A.  Berzofsky, A. N. Schechter,  and D.  H. Sachs,  manuscript  in 
preparation).  The specificities of the antibodies produced are examined in this 
regard in the accompanying paper (7). 
This similarity of response pattern for whole nuclease and one of its fragments 
is only a  correlation, and not proof that the same gene controls their respective 
responses. If the same gene is responsible, the Ir-nuclease gene defined earlier 
(3) may be involved in the control of recognition of a determinant in the region 
between residues 99 and 149. It is of conceptual interest that the Ir-gene control 
appears clearly all-or-none when one looks at a restricted region of the protein 
antigen rather than high-or-low as found for the whole complex antigen.  This 
phenomenon may explain why most Ir genes have been defined for relatively 
simple antigens with few distinct determinants.  The presence of other determi- 
nants which an animal  can recognize partially masks selective defects in the 
immune response to a whole complex antigen. 
Second, it is apparent from Table I that the DBA/1 mice are nonresponders to 
nuclease  and  any  of its  fragments,  even  after  multiple  boosts.  Thus,  if we 
compare the patterns of the DBA/1 and C57BL/10 mice, it would appear that the 
DBA/I mice have at least one additional defect not found in the C57BL/10 mice. 
In this way we may tentatively define an additional Ir gene (or genes) involved 
in the antibody response to nuclease. Since in an earlier study (3) the SJL  × 
DBA/1 combination was subjected to a formal genetic analysis in the F2 genera- 
tion which showed Ir-gene linkage to H-2, and since the SJL is a responder to all 
the regions of nuclease tested,  it is probable that  both Ir-gene  defects in the 
DBA/1  strain  are  H-2  linked.  At  the  present  time,  however,  it  would  be 
premature  to conclude that  both genes are  in the H-2  complex,  since the  F2 
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This definition of more than one Ir gene controlling the response to nuclease 
should not be confused with the two-gene hypotheses of Munro and Taussig (20) 
and  Dorf et  al.  (21).  Rather  than  being  complementing  genes which control 
different events in the response to the  same antigen,  the two or more genes 
suggested for nuclease are thought to control the response to different determi- 
nants on the molecule. 
Third,  we have noted that  hyperimmunization  of the  nonresponder  DBA/1 
mice appeared on occasion to result in sera that have a lower binding activity for 
the immunogen than do the preimmunization  sera from the same mice. If the 
observation  represents  a  real  immunological  phenomenon,  several  possible 
explanations may be suggested, such as suppression of natural antibody or the 
production of anti-idiotype antibodies. Experiments are currently in progress to 
test these possibilities.  However, the binding  activity in the preimmune  sera 
was of very low affinity (<105 M -1) and is therefore not likely to be ~natural" 
antibody. 
Finally, the hypothesis that a  fragment exhibiting predominantly '~random" 
conformation  2 may be under the same Ir-gene control as the native protein from 
which it was derived suggests marked differences between the conformational 
specificity of the  relevant  receptors for Ir-gene  control  and  of the  antibodies 
ultimately produced. No ordered structure has been detected by physical means 
such as circular dichroism in either fragment  (99-149) or fragment  (1-126). In 
addition, the conformational equilibria of nuclease and its fragments have been 
studied  immunochemically.  Goat  antibodies  to  the  99-126  region  of native 
nuclease cross-react with fragment (99-149) with about 5,000-fold lower affinity 
(22). This difference in affinity has been attributed to a conformational equilib- 
rium  of the fragment  such that  only about one molecule in 103 or 104 is in a 
native-like  conformation  in  solution  at  any moment  (22).  Analogously,  goat 
antibodies to the random conformation fragment  (99-149) cross-react with na- 
tive nuclease  with an  affinity 2,900-fold lower than  that  for the fragment,  a 
result suggesting a similar equilibrium for native nuclease, but in the opposite 
direction (23). 
We have confirmed that the mouse antibodies made to fragments (99-149) and 
(1-126) cross-react very poorly with native nuclease. Thus, the antibodies ulti- 
mately produced distinguish strongly between native and random conformation. 
If it is not coincidental  that the response to the random fragment  (99-149)  is 
under  genetic  control  in  the  same  pattern  as  that  to  native  nuclease,  two 
explanations  may be suggested:  either  (a)  the  relevant  determinant  on this 
antigen  which determines Ir gene-controlled recognition is either  sufficiently 
flexible or sufficiently short that its predominant conformation in solution is the 
same in whole nuclease as in the fragment, or (b) the cell receptors which are 
relevant for Ir gene control of nuclease are much less conformationally specific 
than  the  antibody  ultimately  produced.  At  present,  we  cannot  distinguish 
between these possibilities, nor do we know how generalizable this phenomenon 
may be to other systems. 
Summary 
The progression of the Ir gene-controlled antibody response to staphylococcal 
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control of the response to a  single immunization with 100  ~g of nuclease in 
complete Freund's adjuvant was confirmed. However, among strains of  the high 
responder H-2~1 haplotype, the response of  the A/J mice was about 10-fold higher 
than that of the B10.A, indicating additional non-H-2-1inked control. In addi- 
tion, the low responder C57BL/10 (H-2 b) strain produced antibody levels as high 
as or higher than those of  the congenic high responder B10.A (H-2 ~) strain when 
both strains were repeatedly immunized, indicating complexity even in the H-2- 
linked control of the response to this small monomeric protein. 
Polypeptide fragments of nuclease were  also studied as immunogens. The 
antibody response to one fragment (residues 99-149)  was found to follow the 
same pattern among five strains tested as that to whole nuclease. However, in 
this  case  the  C57BL/10  was  found to be  a  nonresponder rather than  a  low 
responder,  failing to  develop a  response  despite repeated  immunizations. In 
contrast, the C57BL/10 showed a  low but significant response to another frag- 
ment (residues 1-126) of nuclease. These results suggest that the apparent H-2- 
linked control of the response to whole nuclease is a reflection of the ability to 
recognize a  determinant(s) in the region from residues 99 to 149, and that the 
eventual response of the C57BL/10 strain after hyperimmunization reflects the 
recognition of other  determinants.  If these  observations reflect the  common 
recognition of a determinant on native nuclease and on a random-conformation 
fragment, they have implications about the conformational specificity of the 
receptors, or the flexibility of the determinants, involved in H-2-1inked Ir-gene 
control. In addition, evidence is presented for a possible second H-2-1inked gene 
(or genes) controlling the response to other determinants of nuclease expressed 
on the polypeptide fragments. 
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